CCM Patient Conference 2023 - Keynote Speech by Recursion CEO & Co-founder Chris Gibson

To kick off the 2023 CCM Patient Conference in Miami on July 7, 2023, Chris Gibson, our co-founder and CEO, gave a heartfelt and engaging keynote speech on our efforts to discover and develop potential CCM treatments and industrialize drug discovery.
To learn more about the Alliance to Cure Cavernous Malformation, go to www.AllianceToC....
About Recursion:
Recursion is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale - up to millions of wet lab experiments weekly - and massive computational scale - owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology, and chemistry to advance the future of medicine.
Visit www.recursion.... to learn more.
#biology #chemistry #data #datascience #techbio #drugdiscovery #biotech #biotechnology #healthcare #health #medicine #CCM #patients #ai #artificialintelligence #machinelearning #ml

[@sloflo1]

Chris Gibson, you are making $8 million dollars per year. Cut that to $1m so that you don’t have to keep diluting shares to pay your employees and other bills. Get your mind into start up mode until you get paid for molecule.